CB Insights
Technology Market Intelligence
Technology Market Intelligence
Eisai Corporation is a global pharmaceutical company committed to making contributions to better healthcare for patients and their families.
Company (Alive / Active)
Phone: 81-3-3817-3700
4-6-10 Koishikawa
Bunkkyoku
Tokyo, 112-8088
Japan
| Total Funding | Date of Last Funding | |
|---|---|---|
| Eisai Corporation | $0M | Dec 29, 2020 |
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Company | Status | Description | Investors |
|---|---|---|---|
| Osaka, Japan | IPO / Went public | Sumitomo Dainippon Pharma (TYO: 4506) is a pharmaceutical company that develops, manufactures, markets, and distributes pharmaceuticals, food additives, veterinary products, diagnostic agents, and research materials. | Login to see details |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Container | Jan 05, 2018 | Dec 15, 2020 | Patent |
| Tetrasubstituted alkene compounds and their use | Sep 22, 2017 | Dec 01, 2020 | Patent |
| Chiral reagents for preparation of substituted phosphorodiamidate morpholino oligomers | Sep 17, 2019 | Nov 17, 2020 | Patent |
| Anti-tau antibodies and uses thereof | Oct 16, 2018 | Nov 10, 2020 | Patent |
| High-purity quinoline derivative and method for manufacturing same | Sep 03, 2019 | Nov 03, 2020 | Patent |
